Advanced search
Publication Cover
Drug Design, Development and Therapy Volume 10, 2016 - Issue
Submit an article Journal homepage
83
Views
9
CrossRef citations to date
0
Altmetric
Original Research

Efficacy and tolerability of vilazodone for major depressive disorder: evidence from phase III/IV randomized controlled trials

Ligen Shi1 Department of Psychiatry, The Fourth Affiliated Hospital of Zhejiang University School of Medicine, Yiwu;2 Department of Neurosurgery, The Second Affiliated Hospital, School of Medicine, Zhejiang University, Hangzhou, Zhejiang, People’s Republic of China
,
Jingyi Wang1 Department of Psychiatry, The Fourth Affiliated Hospital of Zhejiang University School of Medicine, Yiwu
,
Shenbin Xu2 Department of Neurosurgery, The Second Affiliated Hospital, School of Medicine, Zhejiang University, Hangzhou, Zhejiang, People’s Republic of China
&
Yunrong Lu1 Department of Psychiatry, The Fourth Affiliated Hospital of Zhejiang University School of Medicine, YiwuCorrespondence[email protected]
Pages 3899-3907 | Published online: 25 Nov 2016

Citations (9)

Keep up to date with the latest research on this topic with citation updates for this article.

Subscribe to citation updates

Read on this site (1)

Elisa Brietzke, Gustavo H. Vazquez, Melody J.Y. Kang & Claudio N. Soares. (2019) Pharmacological treatment for insomnia in patients with major depressive disorder. Expert Opinion on Pharmacotherapy 20:11, pages 1341-1349.
Read now

Articles from other publishers (8)

Jiao-Zhao Yan, Guang-Xiang Li, Si-Rui Sun, Lin-Yu Cui, Yong-Yu Yin & Yun-Feng Li. (2024) A rate-limiting step in antidepressants onset: Excitation of glutamatergic pyramidal neurons in medial prefrontal cortex of rodents. Progress in Neuro-Psychopharmacology and Biological Psychiatry 130, pages 110911.
Crossref
Muhammad Azhar Nisar & Muhammad Zubair Saleem. 2023. How Synthetic Drugs Work. How Synthetic Drugs Work 161 176 .
Rohini D Ankushe, VINOD S DESHMUKH, Ashish H Chepure & Jugalkishore B Jaju. (2022) A COMPARATIVE STUDY OF EFFICACY, SAFETY, AND ONSET OF ACTION OF VILAZODONE WITH ESCITALOPRAM IN PATIENTS OF MAJOR DEPRESSIVE DISORDER AT TERTIARY CARE HOSPITAL. Asian Journal of Pharmaceutical and Clinical Research, pages 113-117.
Crossref
James Clevenger & Daniel McCabe. (2020) Development of severe serotonin syndrome from acute ingestion of vilazodone without co-ingestion. The American Journal of Emergency Medicine 38:5, pages 1045.e1-1045.e2.
Crossref
Yang Zhang, Guoxun Zheng, Tingting Fu, Jiajun Hong, Fengcheng Li, Xiaojun Yao, Weiwei Xue & Feng Zhu. (2020) The binding mode of vilazodone in the human serotonin transporter elucidated by ligand docking and molecular dynamics simulations. Physical Chemistry Chemical Physics 22:9, pages 5132-5144.
Crossref
Simone B. Sartori & Nicolas Singewald. (2019) Novel pharmacological targets in drug development for the treatment of anxiety and anxiety-related disorders. Pharmacology & Therapeutics 204, pages 107402.
Crossref
Li-jun Sun, Li-ming Zhang, Dan Liu, Rui Xue, Yan-qin Liu, Lei Li, Ying Guo, Chao Shang, Jun-qi Yao, You-zhi Zhang & Yun-feng Li. (2019) The faster-onset antidepressant effects of hypidone hydrochloride (YL-0919). Metabolic Brain Disease 34:5, pages 1375-1384.
Crossref
Maria Bogdan, Eliza Gofita, Daniela Cornelia Calina, Adina Turcu-Stiolica, Anca Oana Docea, Tudor Adrian Balseanu, Adrian Camen, Gratiela Eliza Popa, Gabriela Rusu, Ina Cristofor, Liliana Pavel & Liliana Mititelu-Tartau. 2018. Pharmacokinetics and Adverse Effects of Drugs - Mechanisms and Risks Factors. Pharmacokinetics and Adverse Effects of Drugs - Mechanisms and Risks Factors.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.